MSOs And Cannabis Rescheduling: A Safer Bet? Analyst Looks Closer At Pros And Cons
Portfolio Pulse from Nicolás Jose Rodriguez
Analysts from Zuanic & Associates (Z&A) have discussed the potential impact of cannabis rescheduling on Multi-State Operators (MSOs) and cannabis stocks. They suggest that rescheduling may not be beneficial for MSOs and that the industry should consider the consequences of medical marijuana rescheduling. They also recommend lobbying for the removal of 280E without rescheduling. The report mentions several cannabis ETFs, including Cambria Cannabis ETF (TOKE), Amplify Seymour Cannabis ETF (CNBS), AdvisorShares Pure Cannabis ETF (YOLO), ETFMG Alternative Harvest (MJ), AXS Cannabis ETF (THCX), and Global X Cannabis ETF (POTX).
July 31, 2023 | 10:14 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amplify Seymour Cannabis ETF (CNBS) is mentioned in the report discussing potential impact of cannabis rescheduling.
The potential rescheduling of cannabis could have an impact on the performance of cannabis-related ETFs like CNBS. However, the exact impact is uncertain.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
ETFMG Alternative Harvest (MJ) is mentioned in the report discussing potential impact of cannabis rescheduling.
The potential rescheduling of cannabis could have an impact on the performance of cannabis-related ETFs like MJ. However, the exact impact is uncertain.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Global X Cannabis ETF (POTX) is mentioned in the report discussing potential impact of cannabis rescheduling.
The potential rescheduling of cannabis could have an impact on the performance of cannabis-related ETFs like POTX. However, the exact impact is uncertain.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
AXS Cannabis ETF (THCX) is mentioned in the report discussing potential impact of cannabis rescheduling.
The potential rescheduling of cannabis could have an impact on the performance of cannabis-related ETFs like THCX. However, the exact impact is uncertain.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Cambria Cannabis ETF (TOKE) is mentioned in the report discussing potential impact of cannabis rescheduling.
The potential rescheduling of cannabis could have an impact on the performance of cannabis-related ETFs like TOKE. However, the exact impact is uncertain.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
AdvisorShares Pure Cannabis ETF (YOLO) is mentioned in the report discussing potential impact of cannabis rescheduling.
The potential rescheduling of cannabis could have an impact on the performance of cannabis-related ETFs like YOLO. However, the exact impact is uncertain.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50